Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Orlistat in African American and Caucasian Children and Adolescents With Obesity-Related Comorbid Conditions
NCT00001723Phase 2Completed
- Sponsor
- Jack Yanovski
- Start
- May 1998
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity comparing Placebo with Orlistat (2 arms). Primary endpoint: Change in Body Mass Index Standard Deviation Score at 6 months. Started May 1998; status: completed.
02
Drugs
orlistat
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00001723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001723.